Summary
Synalbumin extracts prepared from normal and diabetic plasma were examined for their capacity to antagonise insulin-promoted glycine-1-14C uptake and protein synthesis by rat diaphragm. Ten out of 12 diabetics showed significant antagonism as against 2 of 11 healthy volunteers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alp H., Recant L.: Studies on the Insulin Inhibitory Effect of Human Albumin — J. clin. Invest.44, 870, 1965.
Bajaj J. S., Bansal D. D., Gupta S. K.: Synalbumin Insulin Antagonism in Northern India — Acta diabet. lat.8, 288, 1971.
Bajaj J. S., McMaster D., Vallance-Owen J.: Further Studies on the Incidence of the Synalbumin Insulin Antagonist — Diabetologia7, 136, 1971.
Bajaj J. S., Yadav H. S.: Synalbumin Insulin Antagonism and Diabetes Mellitus — In:Viswanathan M., Krishaswami C. V. (Eds): Proceedings of the 1st National Conference on Diabetes. Ravi Press, Madras, 1970; p. 183.
Buse M., McMaster J., Buse J.: Effect of Human Serum Albumin on the Glucose Metabolism of Isolated Rat Diaphragm and its Response to Insulin — Diabetes15, 388, 1966.
Debro J. R., Tarver H., Korner A.: The Determination of Serum Albumin and Globulin by a New Method — J. Lab. clin. Med.50, 728, 1957.
Ditschuneit H.: Definition and Criteria of Prediabetes — In:Östman J., Milner R. D. G. (Eds): Diabetes. Excerpta Medica Foundation, Amsterdam, 1969; p. 479.
Ehrlich R. M., Martin J. M.: Presence of Synalbumin Antagonist in Siblings of Diabetic Children — Diabetes15, 400, 1966.
Ensinck J. W., Poffenbarger P. L., Hogan R. A., Williams R. H.: Studies of Insulin Antagonism. I. An Artifactual Antagonist to Insulin and Plasma Nonsuppressible Insulin-Like Activity Occuring in Preparation of Albumin — Diabetes16, 289, 1967.
Geevarghese P. J.: Pancreatic Diabetes — Popular Prakashan, Bombay, 1968.
Gemmill C. L.: The Effect of Glucose and of Insulin on the Metabolism of the Isolated Diaphragm of Rat — Bull. Johns Hopk. Hosp.68, 329, 1941.
Gey G. O., Gey M. K.: Maintenance of Human Normal Cells and Tumor Cells in Continuous Culture. Preliminary Report: Cultivation of Mesoblastic Tumors and Normal Tissue and Notes on Methods of Cultivation — Amer. J. Cancer27, 45, 1936.
Jervell J.: Insulin Antagonistic Effect of Human Plasma Albumin on Protein Synthesis in Vitro and on Glycogen Synthesis in Vivo in the Rat Diaphragm Muscle — Acta physiol. scand.66, 300, 1966.
Kammerer L., Bretan M., Nemesansky L., Jacob L., Virag S.: A Plasma Synalbumin Antagonist — Lancet2, 1366, 1966.
Keen H.: Properties of Human ‘Albumin’. A Metabolic Study of Albumin Extracts from Normal and Diabetic Plasma — Diabetes12, 406, 1963.
Lowry D. H., Rosebrough N. J., Farr A. L., Randall R. J.: Protein Measurement with Folin Phenol Reagent — J. biol. Chem.193, 265, 1951.
Manchester K. L., Young F. G.: The Effect of Insulin on Incorporation of Amino Acids into Protein of Normal Rat Diaphragm in Vitro — Biochem. J.70, 353, 1958.
Sharma N. C., Sur B. K.: Improved Method for Estimating Blood Sugar — J. clin. Path.19, 630, 1966.
Sherman L.: The Vallance-Owen (Synalbumin) Insulin Antagonist. Reproducibility and Reliability of Results in Non-Diabetic and Diabetic Humans — Diabetes15, 149, 1966.
Vallance-Owen J.: Insulin Antagonists — In:Leibel B. S., Wrenshall G. S. (Eds): On the Nature and Treatment of Diabetes. Excerpta Medica Foundation, Amsterdam, 1967; p. 340.
Vallance-Owen J., Dennes E., Campbell P. N.: The Nature of the Insulin Antagonist Associated with Plasma Albumin — Lancet2, 696, 1958.
Vallance-Owen J., Lilley M. D.: An Insulin Antagonist Associated with Plasma Albumin — Lancet1, 804, 1961.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bajaj, J.S., Bansal, D.D. & Jindal, H.O. Synalbumin insulin antagonism and protein synthesis. Acta diabet. lat 11, 428–431 (1974). https://doi.org/10.1007/BF02624581
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624581